Fluorescence in situ hybridisation for interphase chromosomal aberration-based biological dosimetry.

Authors:
Meher PK; Lundholm L; Wojcik A.

Journal:
Radiat Prot Dosimetry

Publication Year: 2023

DOI:
10.1093/rpd/ncac264

PMCID:
PMC10505941

PMID:
37721087

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Radiat Prot Dosimetry

Abbreviation: Radiat Prot Dosimetry

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Nuclear Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
X-ray scatter in projection radiography.
Ylimaula S; Räsänen L; Hurskainen M and 4 more (2024) - Transparency Score: 1/6
Analysis of radioactivity in commercially available products aiming to improve health and wellness.
Thomas R; Forssell-Aronsson E; Hjellström M and 3 more (2023) - Transparency Score: 2/6
An anthropomorphic body phantom for the determination of calibration factor in radionuclide treatme…
Kovan B; Demir B; Işık EG and 5 more (2023) - Transparency Score: 2/6
ASSESSMENT OF PCXMC MONTE CARLO SIMULATIONS IN SLOT-SCANNING-BASED EXAMINATIONS: COMPARISON WITH IN…
Piai A; Loria A; Tiberio P and 4 more (2023) - Transparency Score: 1/6
A SURVEY OF THE RADIOFREQUENCY ELECTROMAGNETIC ENERGY ENVIRONMENT IN MELBOURNE, AUSTRALIA.
Henderson S; Bhatt C; Loughran S. (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare that they have no conflicts of interest."

Evidence found in paper:

"Funding Swedish Radiation Safety Authority (SSM, projects SSM2019-9651 and SSM2020-2054)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025